Form 8-K · Item 4.01 · Auditor change
Obsidian Therapeutics, Inc.: auditor change, KPMG LLP engaged
Obsidian Therapeutics, Inc. reported in a Form 8-K filed August 3, 2026, that on August 3, 2026, KPMG LLP was engaged.
In the filing's words
On August 3, 2026, the Audit Committee recommended, and the Board subsequently approved, the engagement of KPMG LLP (“KPMG”) as the independent registered public accounting firm of the Parent to audit the consolidated financial statements of the Parent as of and for the year ended December 31, 2026.
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | Obsidian Therapeutics, Inc. |
|---|---|
| Ticker | OBX |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | August 3, 2026 |
| What the filing states | engaged |
| Former accountant | Not established by the filing |
| New accountant | KPMG LLP |
| Date of the change | August 3, 2026 |
| Disagreements | not stated |
| Accession number | 0001193125-26-330810 |
| SEC CIK | 0002130606 |
Obsidian Therapeutics, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed August 3, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Form 8-K, Item 4.01 · accessed 2026-10-23
Documented unknowns
- former_auditor: The filing does not name the former auditor.
More: all auditor changes · Something wrong? Send a correction with the primary source.